← Leaderboards
Janet Patricia Hapgood
University Of Cape Town
$2,405,360
Attributed
$4,810,720
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $653.5K · FY2015–24$1M$750K$500K$250K$0
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
Funding mix
By agency
NIH$4,810,720 · 2
By mechanism
R01$4,810,720 · 2
Top collaborators
- Zdenek Hel6 shared
- Pai-Lien Chen3 shared
- Charles Morrison2 shared
Most similar at University Of Cape Town
Same institution · by research overlap
- Linda-Gail Bekker$40,471,276
- Robert John Wilkinson$5,301,802
- Sean Adam Wasserman$2,761,994
- Mpiko Ntsekhe$1,390,313
- Elisa Nemes$3,140,207
Others in their field
Top investigators on “Levonorgestrel”
- Walter C. Willett · Harvard University (Sch Of Public Hlth)$10,376,483
- Dart Clint · Health Decisions, Inc.$6,166,065
- Meredith R Clark · Eastern Virginia Medical School$6,145,130
- Lisa C Rohan · Magee-Women'S Hospital Of Upmc$6,061,707
- David Turok · University Of Utah$4,534,368
- Rena Chiman Patel · University Of California, San Francisco$3,403,236
Research focus
LevonorgestrelInvestigationExhibitsIn VitroInsightInternationalContraceptive AgentsDoseHiv-1High RiskInfectionInjectableCell ModelAreaAfrica South Of The SaharaCellsAndrogensContraceptive MethodsAffectBiologicalGenesGlucocorticoid ReceptorImmune FunctionMedroxyprogesterone 17-Acetate
Grant awards (11)
Biological effects, hormone levels and mechanisms relevant to HIV-1 infection for women randomized to the injectable contraceptives depo-medroxyprogesterone acetate or norethisterone enanthate.$653,530
R01 · FY2024 · AI · contact PI
Biological effects, hormone levels and mechanisms relevant to HIV-1 infection for women randomized to the injectable contraceptives depo-medroxyprogesterone acetate or norethisterone enanthate.$629,850
R01 · FY2023 · AI · contact PI
Biological effects, hormone levels and mechanisms relevant to HIV-1 infection for women randomized to the injectable contraceptives depo-medroxyprogesterone acetate or norethisterone enanthate.$345,754
R01 · FY2022 · AI · contact PI
Biological effects, hormone levels and mechanisms relevant to HIV-1 infection for women randomized to the injectable contraceptives depo-medroxyprogesterone acetate or norethisterone enanthate.$347,450
R01 · FY2021 · AI · contact PI
Biological effects, hormone levels and mechanisms relevant to HIV-1 infection for women randomized to the injectable contraceptives depo-medroxyprogesterone acetate or norethisterone enanthate.$349,856
R01 · FY2020 · AI · contact PI
Combination treatment for protection against HIV1 and pregnancy$536,621
R01 · FY2019 · HD · contact PI
Combination treatment for protection against HIV1 and pregnancy$538,831
R01 · FY2018 · HD · contact PI
Combination treatment for protection against HIV1 and pregnancy$540,028
R01 · FY2017 · HD · contact PI
Combination treatment for protection against HIV1 and pregnancy$325,041
R01 · FY2016 · HD · contact PI
Combination treatment for protection against HIV1 and pregnancy$212,152
R01 · FY2016 · HD · contact PI
Combination treatment for protection against HIV1 and pregnancy$331,607
R01 · FY2015 · HD · contact PI